Market Overview

Amphastar Pharmaceuticals's Earnings: A Preview


On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Earnings and Revenue

Analysts expect Amphastar Pharmaceuticals earnings of $0.14 per share. Revenue will likely be around $86.62 million, according to the consensus estimate. In the same quarter last year, Amphastar Pharmaceuticals reported EPS of $0.080 on revenue of $79.05 million. If the company were to match the consensus estimate, earnings would be up 75.0%. Amphastar Pharmaceuticals's reported EPS has stacked up against analyst estimates in the past like this:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019
EPS Estimate 0.08 0.07 0.07 0.03
EPS Actual 0.17 0.07 0.10 0.08
Revenue Estimate 82.83 M 81.79 M 78.53 M 77.61 M
Revenue Actual 84.69 M 83.38 M 80.14 M 79.05 M

Stock Performance

Over the last 52-week period, shares are down 1.19%. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Amphastar Pharmaceuticals is scheduled to hold the call at 17:00:00 ET and can be accessed here:


Related Articles (AMPH)

View Comments and Join the Discussion!

Posted-In: Earnings